Scission-Enhanced Molecular Imaging (SEMI).

Area of Science:

• Nuclear medicine
• Molecular imaging
• Radiochemistry

Background:

• Positron emission tomography (PET) and targeted radiotherapeutics are advancing human biology research and clinical practice.
• The field's growth is driven by new ligands, radionuclides, and conjugation chemistries, necessitating improved safety strategies.
• Reducing radiation dose is crucial to minimize patient toxicity and off-target effects from these therapies.

Purpose of the Study:

• To introduce a novel method, scission-enhanced molecular imaging (SEMI), for efficient radionuclide clearance.
• To demonstrate a technique that enhances patient safety by reducing radiation exposure after medical procedures.
• To provide a strategy for managing radiotoxicity in molecular imaging and theranostic applications.

Main Methods:

• Development of a "click-to-release" bioorthogonal linker system.
• Implementation of SEMI for controlled radionuclide elimination.
• Application of the technique in conjunction with PET imaging and radiotherapeutic drug delivery.

Main Results:

• SEMI facilitates rapid elimination of radionuclides from the body.
• The method relies on bioorthogonal chemistry for precise control over linker cleavage.
• Successful application demonstrated the potential for dose reduction and enhanced patient safety.

Conclusions:

• SEMI offers a powerful and simple approach to managing radionuclide burdens post-treatment or imaging.
• The technique addresses the growing need for strategies to mitigate toxicity in nuclear medicine.
• SEMI represents a significant advancement for patient safety in molecular imaging and theranostics.